(Q57768900)

English

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

article

In more languages

Statements

scholarly article

0 references

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007 (English)

0 references

0 references

Julie Bettinger

object named as

Julie A. Bettinger

1

0 references

David W Scheifele

object named as

David W. Scheifele

2

0 references

5

object named as

Wendy Vaudry

0 references

Scott A Halperin

4

object named as

Scott A. Halperin

0 references

author name string

James D. Kellner

3

0 references

Barbara Law

6

0 references

Gregory Tyrrell

7

0 references

language of work or name

0 references

publication date

February 2010

0 references

number of pages

7

1 reference

based on heuristic

inferred from page(s)

0 references

28

0 references

9

0 references

2130-2136

0 references

Bacterial meningitis in the United States in 1995. Active Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Multinational study of pneumococcal serotypes causing acute otitis media in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Invasive pneumococcal infections in Canadian children, 1998-2003: implications for new vaccination programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Progress in the prevention of pneumococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Serotype replacement in perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Editorial Commentary:Replacement Pneumococcal Disease in Perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Impact of conjugate pneumococcal vaccines on antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.026

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.12.026

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57768900&oldid=2078279648"